LAVAL, QC, Feb. 13 /CNW/ - BioSyntech, Inc. (“BioSyntech” or “the Company”) (TSX: BSY), a biotechnology company developing biotherapeutic thermogels for regenerative medicine, today announced its financial results for the three and nine-month periods ended December 31, 2007.
